跳至主要内容
临床试验/ACTRN12624000812594
ACTRN12624000812594尚未招募Unknown

Assessing the effects of a broccoli sprout extract on endothelial function in healthy non-pregnant and pregnant women, and pregnant women with a hypertensive disorder of pregnancy

Monash Health0 个研究点目标入组 30 人开始时间: 2024年7月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
Monash Health
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Group 1: Healthy, non-pregnant women
  • Not pregnant.
  • Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
  • Body mass index (BMI) between 18 – 35kg/m2.
  • 18 years old and over
  • Group 2: Healthy, pregnant women
  • Singleton pregnancy
  • Gestation between 28+0 and 36+0 weeks pregnant.
  • Normal mid-trimester morphology scan, with no detectable significant anomalies.
  • Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
  • Booking body mass index (BMI) between 18 and 35kg/m2.
  • 18 years old and over.
  • Group 3: Pregnant women with a hypertensive disorder of pregnancy
  • Singleton pregnancy
  • Gestation between 28+0 and 36+6 weeks pregnant.
  • Normal mid-trimester morphology scan, with no detectable significant anomalies.
  • Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
  • Booking body mass index (BMI) between 18 and 35kg/m2.
  • 18 years old and over.
  • Diagnosis of preeclampsia or clinical hypertension as defined by the according to the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) guidelines.

排除标准

  • Group 1: Healthy, non-pregnant women
  • Younger than 18 years old
  • Body mass index (BMI) < 18 or > 35kg/m2.
  • Confirmed or suspected pregnancy.
  • Current use of broccoli sprout extract supplement.
  • Contraindications to use (e.g., intolerance of broccoli).
  • Significant uncertainty in ensuring gestational age is within limits.
  • Unwillingness or inability to follow the procedures outlined in the PICF.
  • Mentally, cognitively or legally incapacitated or ineligible to provide informed consent.
  • Co-recruitment/participation in another clinical trial where there is a pharmaceutical or herbal or nutritional intervention (such trial interventions would also include: multi-vitamins, minerals, complementary and alternative medicines).
  • Group 2: Healthy, pregnant women
  • major complications of pregnancy including but not limited to:
  • oFetal growth restriction estimated fetal weight <10th centile or AC (abdominal circumference) <5th
  • oPreeclampsia/HELLP syndrome (haemolysis elevated liver enzymes low platelet syndrome)
  • oGestational diabetes on insulin on >20units insulin/day
  • oPPROM (preterm pre-labour rupture of membranes) within 7 days ago
  • oChorioamnionitis
  • oStillbirth or intrauterine fetal death
  • oSuspected or confirmed congenital infection of pregnancy (i.e. CMV, syphilis, rubella)
  • oUnstable major placenta praevia or vasa praevia
  • oHypertensive disorder of pregnancy on >1 regular anti-hypertensive treatment
  • oAbnormal umbilical artery doppler i.e. elevated umbilical artery doppler pulsatility index (UA PI >95th), absent end-diastolic flow or reversal of end-diastolic flow, or a reduced middle cerebral artery pulsatility index (MCA PI <5th) or abnormal ductus venosus (DV)
  • Renal or hepatic dysfunction.
  • Current use of broccoli sprout extract supplement.
  • Contraindications to use (e.g., intolerance of broccoli).
  • Significant uncertainty in ensuring gestational age is within limits.
  • Unwillingness or inability to follow the procedures outlined in the PICF.
  • Mentally, cognitively or legally incapacitated or ineligible to provide informed consent.
  • Co-recruitment/participation in another clinical trial where there is a pharmaceutical or herbal or nutritional intervention (such trial interventions would also include: multi-vitamins, minerals, complementary and alternative medicines).
  • Group 3: Pregnant women with a hypertensive disorder of pregnancy
  • major complications of pregnancy including but not limited to:
  • oFetal growth restriction estimated fetal weight <10th centile or AC (abdominal circumference) <5th
  • oGestational diabetes on insulin on >20units insulin/day
  • oPPROM (preterm pre-labour rupture of membranes) within 7 days ago
  • oChorioamnionitis
  • oStillbirth or intrauterine fetal death
  • oSuspected or confirmed congenital infection of pregnancy (i.e. CMV, syphilis, rubella)
  • oUnstable major placenta praevia or vasa praevia
  • oAbnormal umbilical artery doppler i.e. elevated umbilical artery doppler pulsatility index (UA PI >95th), absent end-diastolic flow or reversal of end-diastolic flow, or a reduced middle cerebral artery pulsatility index (MCA PI <5th) or abnormal ductus venosus (DV)
  • Current use of broccoli sprout extract supplement.
  • Contraindications to use (e.g., intolerance of broccoli).
  • Significant uncertainty in ensuring gestational age is within limits.
  • Unwillingness or inability to follow the procedures outlined in the PICF.

研究者

发起方
Monash Health

相似试验